fipamezole has been researched along with desipramine in 1 studies
*Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors. [MeSH]
*Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors. [MeSH]
Studies (fipamezole) | Trials (fipamezole) | Recent Studies (post-2010) (fipamezole) | Studies (desipramine) | Trials (desipramine) | Recent Studies (post-2010) (desipramine) |
---|---|---|---|---|---|
5 | 1 | 1 | 5,775 | 487 | 414 |
Protein | Taxonomy | fipamezole (IC50) | desipramine (IC50) |
---|---|---|---|
Solute carrier family 22 member 1 | Homo sapiens (human) | 9.18 | |
5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.35 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0003 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.35 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0034 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0003 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0003 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.35 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.0031 | |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 7.8 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.35 | |
5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | 0.35 | |
5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | 0.35 | |
5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.35 | |
5-hydroxytryptamine receptor 6 | Rattus norvegicus (Norway rat) | 0.35 | |
Histamine H1 receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.1961 | |
5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | 0.35 | |
5-hydroxytryptamine receptor 5A | Rattus norvegicus (Norway rat) | 0.35 | |
5-hydroxytryptamine receptor 5B | Rattus norvegicus (Norway rat) | 0.35 | |
5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.35 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0003 | |
Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | 3.8 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 9.9 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.4035 | |
Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 1.52 | |
5-hydroxytryptamine receptor 4 | Rattus norvegicus (Norway rat) | 0.35 | |
5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.35 | |
Solute carrier family 22 member 2 | Rattus norvegicus (Norway rat) | 10 | |
Transporter | Rattus norvegicus (Norway rat) | 7.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chopin, P; Cussac, D; Funes, P; Heusler, P; Marien, M; Tourette, A; Vacher, B | 1 |
1 other study(ies) available for fipamezole and desipramine
Article | Year |
---|---|
Rigid analogues of the α2-adrenergic blocker atipamezole: small changes, big consequences.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Binding, Competitive; Cells, Cultured; Cricetinae; Cricetulus; Decerebrate State; Frontal Lobe; Humans; Hypothermia; Imidazoles; Male; Mice; Molecular Conformation; Norepinephrine; Polycyclic Compounds; Radioligand Assay; Rats; Stereoisomerism; Structure-Activity Relationship | 2010 |